Skip to Content

How does Lutathera work to treat gastroenteropancreatic neuroendocrine tumors?

Answers (1)

Official Answer by Drugs.com 7 Mar 2018

Lutathera (lutetium Lu 177 dotatate), a Lu-177-labeled somatostatin analogue, is a radioactive drug that binds to a somatostatin receptor on the gastroenteropancreatic neuroendocrine tumor to exert its cancer-killing effect. The FDA approved Lutathera for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in January 2018. GEP-NETs are rare cancers that form in the pancreas, stomach, intestines, colon and rectum.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How does the drug Lokelma work?

Posted 19 Jun 2018 1 answerFAQ by Drugs.com

How do you take Doptelet?

Posted 19 Jun 2018 1 answerFAQ by Drugs.com

What is the difference between Yonsa and Zytiga?

Posted 19 Jun 2018 1 answerFAQ by Drugs.com

Toujeo vs Lantus - What's the difference between them?

Posted 26 Jun 2018 1 answerFAQ by Drugs.com

Toujeo vs Tresiba - What's the difference between them?

Posted 29 Jun 2018 1 answerFAQ by Drugs.com